Home › Funds › SHENKMAN CAPITAL MANAGEMENT INC › HAE
SHENKMAN CAPITAL MANAGEMENT INC position in HAE
HAEMONETICS CORP MASS · Health Care
SHENKMAN CAPITAL MANAGEMENT INC reported holding 1,323,000 shares of HAE (HAEMONETICS CORP MASS) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.31% of its reported portfolio and ranking #43 among its reported holdings. SHENKMAN CAPITAL MANAGEMENT INC has disclosed HAE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SHENKMAN CAPITAL MANAGEMENT INC's HAE position evolved
SHENKMAN CAPITAL MANAGEMENT INC first disclosed a stake in HAE in Q2 2025 at 12,053,000 shares (US$12.4M). Across 6 filings, SHENKMAN CAPITAL MANAGEMENT INC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,323,000 shares valued at US$1.5M. Notable position changes include a 89% trim in Q4 2025 (shares fell 30% over the following quarter), a 42% increase in Q1 2026 (shares rose 33% over the following quarter), a 29% trim in Q2 2026 (shares rose 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 12.05M | $12.39M | New |
| Q3 2025 | 12.14M | $11.56M | Add |
| Q4 2025 | 1.32M | $1.38M | Reduce |
| Q1 2026 | 1.87M | $1.81M | Add |
| Q2 2026 | 1.32M | $1.35M | Reduce |
| Q3 2026 | 1.32M | $1.52M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HAE and 13F data
HAE (HAEMONETICS CORP MASS) is a Health Care company. 24 other funds we track also report a position in HAE — the largest reported positions include ARIEL INVESTMENTS, LLC (US$228.9M), River Road Asset Management, LLC (US$110.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HAE
- ARIEL INVESTMENTS, LLC 2.17M sh · $228.88M · Q3 2026
- River Road Asset Management, LLC 1.05M sh · $110.08M · Q3 2026
More on SHENKMAN CAPITAL MANAGEMENT INC
FAQ
How long has SHENKMAN CAPITAL MANAGEMENT INC held HAE?
SHENKMAN CAPITAL MANAGEMENT INC has disclosed HAE holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is SHENKMAN CAPITAL MANAGEMENT INC's current position in HAE?
As of Q3 2026, SHENKMAN CAPITAL MANAGEMENT INC holds 1.32M shares of HAE (HAEMONETICS CORP MASS), valued at $1.52M, representing 0.31% of its reported portfolio and ranking #43.
Has SHENKMAN CAPITAL MANAGEMENT INC been buying or selling HAE?
In the latest 13F filing (Q3 2026), SHENKMAN CAPITAL MANAGEMENT INC held unchanged its position in HAE.
Which other funds hold HAE?
Other major institutional holders of HAE include ARIEL INVESTMENTS, LLC, River Road Asset Management, LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.